"A
search of the scientific literature to see how this technology works
revealed a surprise: no articles could be located. This led to a
Viewpoint in JAMA in February 2015 in which Theranos was used as an example to question the appropriateness of “stealth research” in biomedicine."
In a spiraling sequence, multiple authorities questioned the work of the company.
No comments:
Post a Comment